Dr. Valentina Sarao is an Assistant Professor of Ophthalmology at the University of Udine, Italy. She is a board-certified ophthalmologist with clinical and research expertise in macular and vitreo-retinal diseases. Her main research interests include diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, cataract, glaucoma, retinal dystrophies, and novel pharmacological and surgical treatments. Dr. Sarao has served as a reviewer for several international peer-reviewed journals in ophthalmology and has authored numerous scientific publications. She is particularly interested in innovative therapies, including anti-VEGF agents, corticosteroids, gene therapy and emerging drug delivery systems.

• Diabetic Retinopathy and Diabetic Macular Edema
• Retinal Vein Occlusion
• Age-Related Macular Degeneration
• Cataract
• Glaucoma
• Retinal Dystrophies
• Anti-VEGF Agents
• Steroids, New Drugs, And Delivery Systems, Gene Therapy

• Avadzadeh S, Sharma A, Parvaresh MM, Ghasemi Falavarjani K; International Retina Biosimilar Study Group (Inter BIOS Group). Aflibercept 2 mg biosimilar (Tyalia)-real-world experience from IRAN (ATRIA study). Eye (Lond). 2025;39(11):2159-2163. doi: 10.1038/ s41433-025-03813-2
• Sarao V, Veritti D, Bonini F, Martin AA, Lanzetta P. Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score–matched analysis. Eye. 2025. Accepted for publication. Status: In press, estimated online publication in March 2025. Collocazione editoriale: Q1
• Veritti D, Sarao V, Lanzetta P. Extended duration of VEGF inhibition with aflibercept 8 mg: the role of reduced ocular clearance. Graefes Arch Clin Exp Ophthalmol. 2025 Jun 2. doi: 10.1007 s00417-025-06847-0.
• Sharma A, Wu L, Bloom S, Stanga P, Eichenbaum DA, Khanani AM, Iuliano L, Veritti D, Sarao V, Lanzetta P, Mirajkar A, Nagpal M, Elwood KF, MacCumber MW, Rezaei KA. RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis. Ophthalmic Surg Lasers Imaging Retina. 2025;56(3):133-135. doi: 10.3928/23258160-20250220-01. Epub 2025 Mar 1. Collocazione editoriale: Q2
• Singh SR, Boscia F, Boscia G, Romano MR, Ferrara M, Menzio S, Veritti D, Sarao V, Lanzetta P, Arevalo JF, Parolini B, Kuppermann B, Singh R, Hassan T, Rezaei K, Wu L, Israilevich R, Starr MR, Chhablani J. Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study. Retina. 2025 Feb 19. doi: 10.1097/ IAE.0000000000004433. Collocazione editoriale: Q1
• Veritti D, Sarao V, Lanzetta P. From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD. Eye (Lond) 2025 Jan 29. doi: 10.1038/ s41433-025-03627-2. Collocazione editoriale: Q1
• Veritti D, Sarao V, Gonfiantini M, Rubinato L, Lanzetta P. Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes. Ophthalmol Ther. 2024 Oct;13(10):2813-2824. doi: 10.1007/s40123-024-01005- x. Epub 2024 Aug 9. PMID: 39122857; PMCID: PMC11408430. Collocazione editoriale: Q1
• Rubinato L, Redolfi de Zan E, Sarao V, Veritti D, Lanzetta P. Stem cell therapy in retinal diseases: current evidence. Expert Review of Ophthalmology 2023; 19(2), 119–131. https://doi.org/ 10.1080/17469899.2023.2296895. Collocazione editoriale: Q3
• Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez Alfageme C, Sivaprasad S, Wakabayashi T, Woo SJ, Sarraf D, Kumar N, Parachuri N, Regillo CD, Rezaei KA, Khanani AM, Bandello F, Shanamugam M, Verma L, Dogra MR, Ns M, Agarwal M, Loewenstein A, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group). Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond). 2024; 38:3392-3395. doi: 10.1038/ s41433-024-03284-x. Collocazione editoriale: Q1
• Ueda-Consolvo T, Ishida M, Nakamura T, Yanagisawa S, Tsuboi K, Wakabayashi T, Hayashi A, Sharma A; International Retina Biosimilar Study Group (Inter BIOS Group).Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study). Eye (Lond). 2024;38:3193-3196. doi: 10.1038/s41433-024-03220-z. Collocazione editoriale: Q1
• Sharma A, Wu L, Bloom S, Stanga P, Walinjkar J, Netralaya SR, Patel AQ, Netralaya R, Nicholson L, Lanzetta P, Veritti D, Sarao V, Boyer D, Cheung CMG, Gupta A, Agrawal V, Rezaei KA. RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema - How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck Retina. Ophthalmic Surg Lasers Imaging Retina. 2024;55:249-252. doi: 10.3928/23258160-20240425-01. Collocazione editoriale: Q2
• Panozzo G, Cicinelli MV, Dalla Mura G, Giannarelli D, Vadalà M, Bonfiglio V, Bellisario G, Bandello F; ESASO Study Group. Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers. Ophthalmol Ther. 2024;13:1383-1398. doi: 10.1007/s40123-024-00925-y. Collocazione editoriale: Q1
• Veritti D, Sarao V, Martinuzzi D, Menzio S, Lanzetta P. Submacular hemorrhage during neovascular age-related macular degeneration: a meta-analysis and meta- regression on the use of tPA and anti-VEGFs. Ophthalmologica. 2024;247:191–202. doi: 10.1159/000537939. Collocazione editoriale: Q1
• Veritti D, Rubinato L, Sarao V, De Nardin A, Foresti GL, Lanzetta P. Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 2024;262:975-982. doi: 10.1007/s00417-023-06245-4. Collocazione editoriale: Q1
• Panozzo G, Franzolin E, Giannarelli D, Dalla Mura G, Longo R, Cicinelli MV; ESASO Study Group. Validation of Esaso Classification of Diabetic Maculopathy. Eur J Ophthalmol. 2024;34:497-501. doi: 10.1177/11206721231186649. Collocazione editoriale: Q2
• Lin TPH, Sen M, Gupta V, Agrawal R, Lanzetta P, Giannaccare G, Chan CKM, Agrawal K, Menia NK, Rojas-Carabali W, Arora A, Martinuzzi D, Taloni A, Rubinato L, Coco G, Sarao V, Veritti D, Chen L, Honavar SG, Lam DSC. Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination. Asia Pac J Ophthalmol (Phila). 2023;12:512-536. doi: 10.1097/ APO.0000000000000647. Collocazione editoriale: Q1
• Sarao V, Veritti D, De Nardin A, Misciagna M, Foresti G, Lanzetta P. Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs. BMJ Open Ophthalmol. 2023;8(1):e001411. doi: 10.1136/bmjophth-2023-001411. Collocazione editoriale: Q2
• Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M. The Present and Future of Optic Pathway Glioma Therapy. Cells. 2023;12:2380. doi: 10.3390/cells12192380. Collocazione editoriale: Q1
• Sharma A, Holz FG, Regillo CD, Freund KB, Sarraf D, Khanani AM, Baumal C, Holekamp N, Tadayoni R, Kumar N, Parachuri N, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group); International Retina Biosimilar Study Group (Inter BIOS Group); Bandello F, Querques G, Loewenstein A, Özdek Ş, Rezai K, Laurent K, Bilgic A, Lanzetta P, Zur D, Yannuzzi N, Corradetti G, Kaiser P, Hilely A, Boyer D, Rachitskaya A, Chakravarthy U, Wintergerst M, Sarao V, Parolini B, Mruthyunjaya P, Nguyen QD, Do D, Keane PA, Hassan T, Sridhar J, Eichenbaum D, Grewal D, Splitzer M. Biosimilars for retinal diseases: United States-Europe awareness survey (Bio USER - survey). Expert Opin Biol Ther. 2023;23:851-859. doi: 10.1080/14712598.2023.2176218. Collocazione editoriale: Q1
• Veritti D, Sarao V, Di Bin F, Lanzetta P. Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose. Pharmaceutics. 2023;15:1416. doi: 10.3390/pharmaceutics15051416. Collocazione editoriale: Q1
• Veritti D, Sarao V, Chhablani J, Loewenstein A, Lanzetta P; Società Italiana della Retina (SIR) Study Group; Intravitreal Injection Setting Study Group (I2SG). The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey. Graefes Arch Clin Exp Ophthalmol. 2023;261:3299-3306. doi: 10.1007/s00417-023-06108-y. Collocazione editoriale: Q1
• Veritti D, Sarao V, Gorni G, Lanzetta P. Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice. Pharmaceutics. 2022;14:265. doi: 10.3390/pharmaceutics14020265. Collocazione editoriale: Q1. Co-primo autore.
• Veritti D, Sarao V, Soppelsa V, Danese C, Chhablani J, Lanzetta P. Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression. J Clin Med. 2022;11:325. doi: 10.3390/jcm11020325. Collocazione editoriale: Q1. Co-primo autore.
• Iglicki M, Busch C, Lanzetta P, Sarao V, Veritti D, Rassu N, Lupidi M, Cebeci Z, Fraser-Bell S, Bernal-Morales C, Sala-Puigdollers A, Zarranz-Ventura J, Gallego-Pinazo R, Maiti A, D'Amico Ricci G, Udaondo P, Loewenstein A, Chhablani J, Zur D. Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study. Eye (Lond). 2022; 37: 280-284. doi: 10.1038/s41433-022-01931-9. Collocazione editoriale: Q1
• Veritti D, Sarao V, Bandello F, Lanzetta P. Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? Eur J Ophthalmol. 2022;32(1):NP345. doi: 10.1177/11206721211053511. Collocazione editoriale: Q2
• Veritti D, Sarao V, Bandello F, Lanzetta P. Lens fogging comment on "Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy". Eur J Ophthalmol. 2022;32:NP349-NP350. doi: 10.1177/11206721211055616. Collocazione editoriale: Q2
• Veritti D, Sarao V, Bandello F, Lanzetta P. Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center. Eur J Ophthalmol. 2022;32:NP346. doi:10.1177/11206721211055617. Collocazione editoriale: Q2
• Veritti D, Sarao V, Bandello F, Lanzetta P. Response to: Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy. Eur J Ophthalmol. 2022;32(1):NP344. doi: 10.1177/11206721211055625. Collocazione editoriale: Q2
• Vujosevic S, Toma C, Sarao V, Veritti D, Brambilla M, Muraca A, De Cillà S, Villani E, Nucci P, Lanzetta P. Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021;10:33. doi: 10.1167/tvst.10.2.33. Collocazione editoriale: Q1
• dell'Omo R, Filippelli M, Virgili G, Bandello F, Querques G, Lanzetta P, Avitabile T, Viola F, Reibaldi M, Semeraro F, Quaranta L, Rizzo S, Midena E, Campagna G, Costagliola C; Eyecare in Italy during COVID-19 pandemic (EICO) study group. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers. Eur J Ophthalmol. 2022;32:695-703. doi: 10.1177/11206721211002442. Collocazione editoriale: Q2
• Veritti D, Sarao V, Soppelsa V, Lanzetta P. Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options. Clin Ophthalmol. 2021;15:375-385. doi: 10.2147/OPTH.S236423. Collocazione editoriale: Q1
• Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, Gambato T, Lanzetta P. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. J Ophthalmol. 2020;2020:4827304. doi: 10.1155/2020/4827304. Collocazione editoriale: Q2
• Sarao V, Veritti D, Lanzetta P. Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study. Graefes Arch Clin Exp Ophthalmol. 2020;258:2647-2654. doi: 10.1007/s00417-020-04853-y. Collocazione editoriale: Q1
• Lanzetta P, Sarao V, Scanlon PH, Barratt J, Porta M, Bandello F, Loewenstein A; Vision Academy. Correction to: Fundamental principles of an effective diabetic retinopathy screening program. Acta Diabetol. 2020;57:907-908. doi: 10.1007/s00592-020-01541-5. Collocazione editoriale: Q1
• Veritti D, Sarao V, Bandello F, Lanzetta P. Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy. Eur J Ophthalmol. 2020;30:621-628. doi: 10.1177/1120672120927865. Collocazione editoriale: Q2. Co-primo autore
• Lanzetta P, Sarao V, Scanlon PH, Barratt J, Porta M, Bandello F, Loewenstein A; Vision Academy. Fundamental principles of an effective diabetic retinopathy screening program. Acta Diabetol. 2020;57:785-798. doi: 10.1007/s00592-020-01506-8. Collocazione editoriale: Q1
• Veritti D, Grego L, Samassa F, Sarao V, Lanzetta P. Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision. J Cataract Refract Surg. 2020;46:662-666. doi: 10.1097/ j.jcrs.0000000000000138. Collocazione editoriale: Q1
• Veritti D, Sarao V, Samassa F, Danese C, Löwenstein A, Schmidt Erfurth U, Lanzetta P. State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration. Expert Opin Pharmacother. 2020;2:773-784. doi: 10.1080/14656566.2020.1736557. Collocazione editoriale: Q2
• Veritti D, Sarao V, De Nadai K, Chizzolini M, Parmeggiani F, Perissin L, Lanzetta P. Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa. J Ocul Pharmacol Ther. 2020;36:190-197. doi: 10.1089/jop.2018.0153. Collocazione editoriale: Q2
• Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Safety of 6000 intravitreal dexamethasone implants. Br J Ophthalmol. 2020;104:39-46. doi: 10.1136/bjophthalmol-2019-313991. Collocazione editoriale: Q1
• Sarao V, Veritti D, Borrelli E, Sadda SVR, Poletti E, Lanzetta P. A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis. BMC Ophthalmol. 2019;19:231. doi: 10.1186/s12886-019-1241-8. Collocazione editoriale: Q2
• Veritti D, Sarao V, Lanzetta P. A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment. J Ophthalmol. 2019;2019:3120960. doi: 10.1155/2019/3120960. eCollection 2019. Collocazione editoriale: Q2
• Sarao V, Veritti D, Maurutto E, Rassu N, Borrelli E, Loewenstein A, Sadda S, Lanzetta P. Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery. Expert Opin Pharmacother. 2018;19:1551-1563. doi: 10.1080/14656566.2018.1516206. Collocazione editoriale: Q2
• Veritti D, Sarao V, Missiroli F, Ricci F, Lanzetta P. TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing. Retina. 2019;39:2077-2083. doi: 10.1097/ IAE.0000000000002299. Collocazione editoriale: Q1
• Borrelli E, Nittala MG, Abdelfattah NS, Lei J, Hariri AH, Shi Y, Fan W, Cozzi M, Sarao V, Lanzetta P, Staurenghi G, Sadda SR. Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy. Br J Ophthalmol. 2018;103:610-6. doi: 10.1136/bjophthalmol-2018-311849. Collocazione editoriale: Q1
• Borrelli E, Lei J, Balasubramanian S, Uji A, Cozzi M, Sarao V, Lanzetta P, Staurenghi G, Sadda SR. Green emission fluorophores in eyes with atrophic age-related macular degeneration: a colour fundus autofluorescence pilot study. Br J Ophthalmol. 2018;102:827-832. doi: 10.1136/bjophthalmol-2017-310881. Collocazione editoriale: Q1
• Al-Khersan H, Hariprasad SM, Chhablani J; Dex Implant Study Group. Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017;184:121-128. doi: 10.1016/j.ajo.2017.10.004. Collocazione editoriale: Q1
• Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P. Fluocinolone acetonide for the treatment of diabetic macular edema. Expert Opin Pharmacother. 2017;18:1507-1516. doi: 10.1080/14656566.2017.1363182. Collocazione editoriale: Q1
• Veritti D, Sarao V, Galiazzo F, Lanzetta P. Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema. Ophthalmologica. 2017;238:100-105. doi:10.1159/000475889. Collocazione editoriale: Q1
• Veritti D, Sarao V, Lanzetta P. Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia. J Ophthalmol. 2017;2017:7545687. doi: 10.1155/2017/7545687. Collocazione editoriale: Q2
• Sarao V, Veritti D, Furino C, Giancipoli E, Alessio G, Boscia F, Lanzetta P. Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study. Acta Ophthalmol. 2017;95(4):e255-e260. doi: 10.1111/aos.13395. Collocazione editoriale: Q1
• Veritti D, Sarao V, Parravano M, Arias L, Varano M, Lanzetta P. One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: a prospective study. Eur J Ophthalmol. 2017;27:74-79. doi: 10.5301/ejo.5000880. Collocazione editoriale: Q2
• Veritti D, Sarao V, Francescutti L, Rota N, Loewenstein A, Borrelli E, Sadda S, Lanzetta P. Optical coherence tomography angiography findings in diabetic retinopathy, Expert Review of Ophthalmology 2017; 12:475-484. doi: 10.1080/17469899.2017.1395698. Collocazione editoriale: Q3
• Chhablani J, Bansal P, Veritti D, Sambhana S, Sarao V, Pichi F, Carrai P, Massaro D, Lembo A, Mansour AM, Banker A, Gupta SR, Hamam R, Lanzetta P. Dexamethasone implant in diabetic macular edema in real-life situations. Eye (Lond). 2016;30:426-30. doi: 10.1038/ eye.2015.246. Collocazione editoriale: Q1
• Sarao V, Parravano M, Veritti D, Arias L, Varano M, Lanzetta P. Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy. Retina. 2016;36:770-777. doi: 10.1097/IAE.0000000000000751. Collocazione editoriale: Q1
• Sarao V, Veritti D, Macor S, Lanzetta P. Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes. Graefes Arch Clin Exp Ophthalmol. 2016;254(3):445-54. doi: 10.1007/s00417-015-3076-1. Collocazione editoriale: Q1
• Sarao V, Bertoli F, Veritti D, Lanzetta P. Author’s response. Expert Opin Pharmacother. 2015;16:448. Collocazione editoriale: Q1
• Sarao V, Bertoli F, Veritti D, Lanzetta P. Pharmacotherapy for treatment of retinal vein occlusion. Expert Opin Pharmacother. 2014;15(16):2373-84. doi: 10.1517/14656566.2014.956083. Collocazione editoriale: Q2
• Sarao V, Veritti D, Boscia F, Lanzetta P. Intravitreal steroids for the treatment of retinal diseases. ScientificWorldJournal. 2014;2014:98950. doi: 10.1155/2014/989501. eCollection 2014. Collocazione editoriale: Q2
• Sarao V, Veritti D, Lanzetta P. Regression of diabetic macular edema after subcutaneous exenatide. Acta Diabetol. 2014;51:505-8. doi: 10.1007/s00592-013-0506-6. Collocazione editoriale: Q1
• Sarao V, Veritti D, Prosperi R, Pignatto S, Lanzetta P. A case of CRB1-negative Coats-like retinitis pigmentosa. J AAPOS. 2013;17:414-6. doi: 10.1016/j.jaapos.2013.02.010. Collocazione editoriale: Q2
• Veritti D, Sarao V, Lanzetta P. Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors. J Ocul Pharmacol Ther. 2013;29:437-41. doi: 10.1089/jop.2012.0173. Collocazione editoriale: Q2
• Veritti D, Sarao V, Lanzetta P. New advances in retina: a report from the International Symposium on Ocular Pharmacology and Therapeutics meeting’, Expert Review of Ophthalmology. 2013;8: 237– 239. doi: 10.1586/eop.13.15. Collocazione editoriale: Q3
• Veritti D, Sarao V, Lanzetta P. Neovascular age-related macular degeneration. Ophthalmologica. 2012;227 Suppl 1:11-20. doi: 10.1159/000337154. Collocazione editoriale: Q1
• Veritti D, Sarao V, Lanzetta P. Online optical coherence tomography during subthreshold laser irradiation. Eur J Ophthalmol. 2012;22:575-9. doi: 10.5301/ejo.5000078. Collocazione editoriale: Q2
• Veritti D, Di Giulio A, Sarao V, Lanzetta P. Drug safety evaluation of intravitreal triamcinolone acetonide. Expert Opin Drug Saf. 2012;11:331-40. doi: 10.1517/14740338.2012.635141. Collocazione editoriale: Q1
• Sarao V, Veritti D, Lanzetta P. Triamcinolone acetonide for the treatment of diabetic macular oedema. European Ophthalmic Review. 2012;6:28–33. doi: 10.17925/EOR.2012.06.01.28. Collocazione editoriale: Q3
• Veritti D, Sarao V, Lanzetta P. Update on combination therapy in wet age-related macular degeneration. Expert Review of Ophthalmology. 2010; 5:681-688. doi: 10.1586/eop.10.62. Collocazione editoriale: Q3

No content available to display!!!

• https://orcid.org/0000-0003-0041-5073
• https://www.scopus.com/authid/detail.uri?authorId=36553352500